PGR and ductal breast carcinoma in situ: Of the 375 cases that received a final diagnosis of pure DCIS (supplementary material, Figure S1A), the samples represented different molecular subtypes based on estrogen receptor (ER), progesterone receptor (PR), and HER2 expression (supplementary material, Figure S1B).